Cannabinoid receptor 2-mediated attenuation of CXCR4-tropic HIV infection in primary CD4+ T cells.
Agents that activate cannabinoid receptor pathways have been tested as treatments for cachexia, nausea or neuropathic pain in HIV-1/AIDS patients. The cannabinoid receptors (CB(1)R and CB(2)R) and the HIV-1 co-receptors, CCR5 and CXCR4, all signal via Gαi-coupled pathways. We hypothesized that drugs...
Guardado en:
Autores principales: | Cristina Maria Costantino, Achla Gupta, Alice W Yewdall, Benjamin M Dale, Lakshmi A Devi, Benjamin K Chen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/872c63a286b44497a740ab34586757bd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Engineering HIV-resistant human CD4+ T cells with CXCR4-specific zinc-finger nucleases.
por: Craig B Wilen, et al.
Publicado: (2011) -
Type 1 diabetes patients increase CXCR4+ and CXCR7+ haematopoietic and endothelial progenitor cells with exercise, but the response is attenuated
por: Guy S. Taylor, et al.
Publicado: (2021) -
T cell-tropic HIV efficiently infects alveolar macrophages through contact with infected CD4+ T cells
por: Abigail E. Schiff, et al.
Publicado: (2021) -
CXCR6+CD4+ T cells promote mortality during Trypanosoma brucei infection.
por: Gongguan Liu, et al.
Publicado: (2021) -
Intravesical CD74 and CXCR4, macrophage migration inhibitory factor (MIF) receptors, mediate bladder pain.
por: Shaojing Ye, et al.
Publicado: (2021)